These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 22975552)

  • 21. Fatal anaphylactic reaction to iron sucrose in pregnancy: iron-induced Kounis syndrome?
    Soufras GD; Kounis GN; Kounis NG
    Indian J Pharmacol; 2013; 45(6):642-3. PubMed ID: 24347784
    [No Abstract]   [Full Text] [Related]  

  • 22. Anemia during pregnancy and in the postpartum: intravenous iron therapy revisited.
    Eur J Obstet Gynecol Reprod Biol; 2005 Dec; 123 Suppl 2():S1-35. PubMed ID: 16360535
    [No Abstract]   [Full Text] [Related]  

  • 23. Intravenous iron in the treatment of anemia of pregnancy. 1949.
    Govan AD; Scott JM
    Eur J Obstet Gynecol Reprod Biol; 2005 Dec; 123 Suppl 2():S33-5. PubMed ID: 16360540
    [No Abstract]   [Full Text] [Related]  

  • 24. [Case of osteomalacia due to intravenous saccharated ferric oxide].
    Nakaoka T; Sugimoto T; Okimura Y; Chihara K
    Nihon Naika Gakkai Zasshi; 1998 Jul; 87(7):1372-3. PubMed ID: 9745288
    [No Abstract]   [Full Text] [Related]  

  • 25. Clinical case reports raise doubts about the therapeutic equivalence of an iron sucrose similar preparation compared with iron sucrose originator.
    Stein J; Dignass A; Chow KU
    Curr Med Res Opin; 2012 Feb; 28(2):241-3. PubMed ID: 22181342
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Safe administration of iron sucrose in a patient with a previous hypersensitivity reaction to ferric gluconate.
    Sane R; Baribeault D; Rosenberg CL
    Pharmacotherapy; 2007 Apr; 27(4):613-5. PubMed ID: 17381390
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Phase III, randomized, open-label trial of ferumoxytol compared with iron sucrose for the treatment of iron deficiency anemia in patients with a history of unsatisfactory oral iron therapy.
    Hetzel D; Strauss W; Bernard K; Li Z; Urboniene A; Allen LF
    Am J Hematol; 2014 Jun; 89(6):646-50. PubMed ID: 24639149
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A 12-week, double-blind, placebo-controlled trial of ferric citrate for the treatment of iron deficiency anemia and reduction of serum phosphate in patients with CKD Stages 3-5.
    Block GA; Fishbane S; Rodriguez M; Smits G; Shemesh S; Pergola PE; Wolf M; Chertow GM
    Am J Kidney Dis; 2015 May; 65(5):728-36. PubMed ID: 25468387
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Intravenous ferric carboxymaltose-associated hypophosphatemia in patients with iron deficiency anemia. A common side effect].
    Sánchez González R; Ternavasio-de la Vega HG; Moralejo Alonso L; Inés Revuelta S; Fuertes Martín A
    Med Clin (Barc); 2015 Aug; 145(3):108-11. PubMed ID: 25579771
    [TBL] [Abstract][Full Text] [Related]  

  • 30. IBD: Intravenous iron in IBD--what's the best preparation?
    Gomollón F; Gisbert JP
    Nat Rev Gastroenterol Hepatol; 2011 Jul; 8(9):477-8. PubMed ID: 21788975
    [No Abstract]   [Full Text] [Related]  

  • 31. Hypophosphatemia induced by intravenous administration of Saccharated iron oxide.
    Okada M; Imamura K; Iida M; Fuchigami T; Omae T
    Klin Wochenschr; 1983 Jan; 61(2):99-102. PubMed ID: 6843038
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Iron hydroxide polymaltose: iatrogenic cause of persistent iron deficiency anaemia despite continuous oral iron therapy.
    Mehta BC
    J Assoc Physicians India; 2002 Feb; 50():279-80. PubMed ID: 12038667
    [No Abstract]   [Full Text] [Related]  

  • 33. Parenteral iron therapy.
    Kaplinsky C
    Isr Med Assoc J; 2008 May; 10(5):372-3. PubMed ID: 18605363
    [No Abstract]   [Full Text] [Related]  

  • 34. Hepatocellular damage following therapeutic intravenous iron sucrose infusion in a child.
    Wood DM; Thomson AH; Lawes M; Jones AL; Dargan PI
    Ther Drug Monit; 2005 Aug; 27(4):405-8. PubMed ID: 16044093
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of different intravenous iron preparations with risk of bacteremia in maintenance hemodialysis patients.
    Sirken G; Raja R; Rizkala AR
    Clin Nephrol; 2006 Nov; 66(5):348-56. PubMed ID: 17140164
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [2 cases of nonspecific multiple ulcers of the small intestine associated with osteomalacia caused by long-term intravenous administration of saccharated ferric oxide].
    Okada M; Imamura K; Fuchigami T; Omae T; Iida M; Nanishi F; Murakami M; Ohgushi H; Yao T; Fujita K; Ogawa K
    Nihon Naika Gakkai Zasshi; 1982 Nov; 71(11):1566-72. PubMed ID: 7166673
    [No Abstract]   [Full Text] [Related]  

  • 37. TIDILAP: Treatment of iron deficiency in lipoprotein apheresis patients --A prospective observational multi-center cohort study comparing efficacy, safety and tolerability of ferric gluconate with ferric carboxymaltose.
    Schatz U; Illigens BM; Siepmann T; Arneth B; Siegert G; Siegels D; Heigl F; Hettich R; Ramlow W; Prophet H; Bornstein SR; Julius U
    Atheroscler Suppl; 2015 May; 18():199-208. PubMed ID: 25936327
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Iron supplementation in preterm infants treated with erythropoietin].
    Picaud JC; Putet G; Salle BL; Claris O
    Arch Pediatr; 1999 Jun; 6(6):657-64. PubMed ID: 10394459
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Iron protein-succinylate in the treatment of adult iron-deficiency anemia].
    Pujol Farriols R; Anglada Oriol M; Formiga Pérez F; Fernández-Sabe N; Mitjavila Vileró F; Vidaller Palacín A
    An Med Interna; 2002 Dec; 19(12):651-2. PubMed ID: 12593038
    [No Abstract]   [Full Text] [Related]  

  • 40. Should intravenous iron be upfront therapy for iron deficiency anemia?
    Auerbach M
    Pediatr Blood Cancer; 2011 Apr; 56(4):511-2. PubMed ID: 21298731
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.